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We describe here the G12 pro-B cell clone that has been isolated from an IL-7 transgenic
mouse. This clone has the phenotype B220 BP-1 /, HSA /, CD43 X5 /, and CD25-, and
has its Ig locus in a germline configuration. G12 cells spontaneously express cell-surface
MHC class II molecules, although to a much lesser extent than the mature M12.4.1 B-cell
lymphoma. G12 cells can process and present the native Hen Egg Lysozyme (HEL) to an
MHC class II-restricted T-cell hybridoma. The efficiency of presentation is inferior to that
obtained with M12.4.1 cells. This is the first report where a pro-B cell can serve as APC in
an MHC class II-restricted presentation.
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INTRODUCTION
The differentiation of B-cell precursors in the bone
marrow occurs through ordered events that com-
prise the successive loss or acquisition of various
cell-surface markers as,well as the progressive rear-
rangement of Ig genes. Several nomenclatures have
been proposed (reviewed by Hardy et al., 1994 and
Rolink et al., 1994). According to the classification of
Rolink et al. (1994), the most immature B cells,
called pro-B cells, sequentially mature into pre-BI,
large pre-BII, small pre-BII, and immature B cells.
Pro-B cells express low levels of the B220 (CD45)
antigen, and are dependent upon a combination of
IL-7 and cell contact with stromal cells for their in
vitro growth. At this stage, the cells are CD43-
positive, and the surrogate light chain (SL), com-
prised of the K5 and Vpre-B molecules, is expressed
and associated with a complex of cell-surface glyco-
proteins (Rolink et al., 1994). The transition be-
tween pro-B and pre-BI cells is marked by the
rearrangement of DH to JH genes. At the large
pre-BII cell stage, cells contain cytoplasmic tH
chain, do not express cell-surface SL anymore,
become CD25-positive, and are able to grow in vitro
in the presence of IL-7 alone. The subsequent small
"Corresponding author.
pre-BII cells lose expression of the CD43 antigen.
They then become immature B cells with surface
expression of the tH chain associated with light
chains and do not respond to IL-7 anymore. Mature
B cells then enter the periphery and coexpress
cell-surface IgM and IgD.
One major point of conflict concerning the B-cell
differentiation pathway is the timing of MHC class
II molecules expression. In the periphery, mature B
cells express class II molecules until the plasma-cell
stage, at which point the expression is down-
regulated. Acquisition of class II molecules by de-
veloping mouse B cells in the bone marrow remains
controversial. Previous studies using flow cytometry
of bone marrow or fetal liver-derived in vitro-
generated pre-B cells failed to demonstrate any
MHC class II expression (Dasch and Jones, 1986;
Rolink et al., 1991). Other studies, using Abelson
murine leukemia virus-transformed or chemically
transformed pre-B cell lines, showed that these cell
lines failed to express class II molecules unless they
were induced by IL-4 (Polla et al., 1986). However,
recent reports have challenged this view. Significant
amounts of class II molecules could be detected on
bone-marrow-derived pre-B cells using a highly
sensitive ELISA test (Miki et al., 1992) or multipa-
rameter flow cytometry (Tarlinton, 1993; Hayakawa
et al., 1994).
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In this report, we characterized a pro-B-cell clone,
derived from an IL-7 transgenic mouse, which
constitutively expresses MHC class II molecules
whose expression can be slightly enhanced by IL-4.
This pro-B-cell clone is able to process the native
Hen Egg Lysozyme (HEL) protein into antigenic
peptides capable of stimulating a class II-restricted
T-cell hybridoma.
RESULTS
Tumors obtained from our IL-7 transgenic mice
were relatively monomorphic, and were mostly
comprised of pro-B and pre-B cells (Fisher et al.,
1993). Cells harvested from the tumors that arose in
the 10-III-101 mouse were cloned in vitro using the
B16.14 cell line as a stromal-cell feeder layer, as
explained in Materials and Methods. The G12 clone
is dependent upon cell contact with the B16.14 cells
for its growth. This clone was analyzed first by
cell-surface staining. As shown in Fig. I(A), no
expression of the myeloid markers Mac-1 and F4/80
was detected. On the contrary, G12 cells were found
positive for B220, which is expressed throughout
the B-cell differentiation pathway. Expression of
CD25 was not detected. Figure I(B) shows that G12
expresses BP-1, CD43, as well as Thy-1 antigens.
Low levels of AA4.1 and 5 molecules were also
detected (in both cases, the peak median was shifted
from 8.9 for the negative control to 14.6). The
expression of AA4.1 is confined to early hemopoi-
etic precursors (McKearn et al., 1985). The Thy-1 Ag
has also been detected on pluripotent stem cells, as
well as on bone-marrow-derived B-cell progenitors
(Tidmarsh et al., 1989). The phenotype B220 /,
BP-1 /, HSA+, CD43 /, X5 +, and CD25- is restricted
to the pro-B/pre-BI cell stage, according to Rolink et
al. (1994) and Hardy et al. (1994).
To define more accurately the differentiation stage
of the G12 cells, we studied the rearrangement
status of the Ig locus. This was analyzed by PCR
using primers hybridizing 5’ to DH and 3’ to JH
segments to detect DH-JH rearrangements, and
primers hybridizing 3’ to DH and 5’ to JH1 segments
to detect a germline fragment. As shown in Fig. 2, in
G12 cells a 1.5-kb band corresponding to a germline
D-JH fragment was detected, whereas no D-JH rear-
ranged segments could be observed. The more
mature 70Z/3 pre-B-cell line has both Ig alleles
rearranged (Alt et al., 1984) and was used as
positive control for D-JH-rearranged fragments and
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FIGURE 1. Cell-surface staining of G12 cells. (A) The staining
of the rat mAb to HSA, F4/80, Mac-l, and B220 molecules was
revealed with a FITC-conjugated anti-rat mAb. Analysis of CD25
expression was performed with a phycoerythrin-conjugated
mAb. Means of fluorescence intensity are indicated. (B) The
binding of the biotinylated mAbs to AA4.1, BP-1, Lamda-5,
Thy-1, B7.1, and CD43 was visualized with avidin coupled to
FITC.
negative control for germline DNA. The germline
configuration of the Ig locus of G12 cells indicated
that these cells are pro-B cells according to Rolink
et al. (1994).
We next assessed the expression of MHC class II
molecules using the M5/114 mAb. This rat mAb
detects I-Ab, I-Ad, I-Aq, and I-Ek molecules but not
I-Af, I-Ak, and I-As molecules (Bhattacharya et al.,
1981). Because the G12 clone arose in a mouse
issued from a crossing between an IL-7 transgenic
mouse to DBA/2 (see Materials and Methods), at
least one allele of its MHC is H-2d. Indeed, G12 cells
are stained with the M5/114 mAb, but the mean
fluorescence intensity was approximately 10 times
less than that obtained with the mature M12.4.1 B
lymphoma cells (Fig. 3(A). The cell-surface detectionMHC CLASS II IN PRO-B CELLS 87
FIGURE 2. Southern blot analysis of PCR amplification. Am-
plified DH-JH-rearranged fragments (lanes and 2) or germline
fragments (lanes 3 and 4) were generated with DNA from G12
cells (lanes and 3) or from 70Z/3 cells (lanes 2 and 4).
was much more sensitive when the rat M5/114
mAb was used instead of conventional mouse class
II-specific mAbs, such as MKD6 or 40B (data not
shown). We believe this may be due to a higher
affinity of the xenogenic M5/114 mAb. Intracellular
staining revealed a weak expression of the invariant
chain (Ii) in G12 compared with M12.4.1 (Fig. 3 (B)).
In these stainings, anti-CD8 H35.17 mAb served as
an isotype control, all three mAbs being rat IgG2b.
As already described (Polla et al., 1986), the chem-
ically transformed 70Z/3 pre-B-cell line did not
stain either at the cell-surface or intracellularly with
M5/114 and anti-Ii mAb.
We next looked for MHC class II transcripts in
G12 cells, using an I-A probe. After $1 digestion of
the RNA/DNA probe hybrids, a protected fragment
yielding a band of approximately 440 bp was de-
tected in the M12.4.1 positive control as well as with
G12 RNA extract. No protected fragment could be
detected with the negative control 70Z/3 nor with
the B16.14 RNA extract. Indeed, the B16.14 cell line
has been found negative for class II expression by
flow cytometry, although this expression can be
induced when the cells are grown at 33C in the
presence of IFN-/ (data not shown). Uncut probe
(520 bp) remained visible in all four samples.
Having established that the pro-B G12 cells ex-
press MHC class II molecules, we next examined
their ability to bind peptides either endogenously
processed or exogenously provided. The presence of
a cell-surface stable complex between MHC class II
molecules and an antigenic peptide was assessed by
the stimulation of IL-2 production by a relevant spe-
cific T-cell hybridoma. Figure 5(A) shows that the
presentation of the HEL protein to the I-Ed-restricted
HEL-specific G28 T-cell hybridoma is far less effi-
cient by G12 than by M12.4.1 cells. Efficiency of
presentation was similar only at the highest dose of
HEL (10 mg/ml). For lower doses of antigen, T-cell
response obtained with M12.4.1 cells remained at
the plateau stage, whereas the T-cell response ob-
tained with G12 cells decreased abruptly. Only doses
ranging down to 1 mg/ml resulted in a significant
T-cell response. When G12 cells were pretreated
with 20% IL-4-containing supernatant for 48 hr
prior to the T-cell stimulation test, a slight increase
(7%) in the mean fluorescence intensity of class II
molecules was detected by flow cytometry (data not
shown). This pretreatment with IL-4 also increased
the efficiency of antigen presentation (Fig. 5(A)).
Similar results were obtained with the presentation
of exogenously added synthetic (HEL (106-116)
peptide (Fig. 5(B)). Curiously, the efficiency of pep-
tide.presentation by G12 cells never reached the high
efficiency obtained by M12.4.1 cells, even at high
peptide concentration (62.5 tg/ml).
DISCUSSION
In this report, we have shown that MHC class II
molecules can be expressed by an early B-cell pre-
cursor, namely, the G12 pro-B-cell clone. The level of
class II expression by the G12 cells is about 10 times
less than that found on a mature B-cell lymphoma
line. Staining with the anti I-Ad MKD6 mAB (not
shown), as well as the efficient presentation of the
I-Ed-restricted HEL(106-116) epitope indicates that
both I-Ad and I-E
d molecules are expressed by G12
cells. The fact that the IL-7 transgene is under the
control of the I-Ea promoter might suggest that class
II-positive B cells would be autonomous of exoge-
nous IL-7. However, G12 cells are totally dependent
upon cell contact with B16.14 stromal cells and do
not grow autonomously. The constitutive synthesis
of IL-7 in our transgenic mouse results in the selec-
tive expansion of IL-7 responsive early B cells. Sev-
eral other pro-B-cell clones have been derived from
our IL-7 transgenic mice, and most do not express
MHC class II molecules (Fisher et al., in press), indi-
cating that the onset of MHC class II expression by
G12 cells is not due to excessive signaling of IL-7
through the shared IL-7/4 receptor chain (Noguchi
et al., 1993; Russel et al., 1993; Kondo et al., 1994).





FIGURE 3. Flow cytometry analysis of MHC class II expression. (A) Cell-surface staining or (B) intracellular staining was performed
with M12.4.1, G12, and 70Z/3 cells. MHC class II molecules were detected with M5/114 rat mAb, and invariant chain with In1 rat
mAb. Profiles corresponling to In1 stain are indicated by an arrow.
by bone marrow B cells has been reinvestigated.
Staining profiles obtained with fresh, polyclonal
populations of pro-B cells, defined as B220
/ CD43 /,
showed that class II expression was barely (Tar-
linton, 1993) or not (Hayakawa et al., 1994) detect-
able. This may indicate that the onset of class II
expression is an early and progressive event in the
mouse B-cell maturation pathway; hence, only a
small percentage of pro-B cells may be class II
positive.
IL-4 is known for inducing MHC class II cell-
surface expression in pre-B-cell lines as well as for
increasing class II expression in resting peripheral B
lymphocytes (Noelle et al., 1984; Polla et al., 1986).
The presentation of the I-Ed-restricted HEL(106-
116) epitope, which was increased when G12 cells
were pretreated with IL-4, indicates that these pro-B
cells can serve as APC. However, the presentation
efficiency obtained with the G12 cells was always
considerably less than that obtained with M12.4.1
cells. This was true with the native HEL protein as
well as with added HEL(106-116) synthetic peptide,
indicating that the difference observed is not due to
FIGURE 4. Detection of MHC class II transcripts by $1 nuclease
analysis. RNA extracts from M12.4.1, G12, 70Z/3, and B16.14
cells (lanes to 4, respectively) were hybridized with a 520-bpA
probe. After $1 digestion, a 440-bp protected fragment was seen
with M12.4.1 and G12 RNA extracts.MHC CLASS II IN PRO-B CELLS 89
a major defect in the processing machinery of the
G12 cells. One intriguing observation in our study is
that, at high doses, the presentation of the native
HEL protein by G12 cells is comparable to that
obtained with the mature M12.4.1 B cells, whereas
the optimal presentation by G12 cells of the exo-
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ways much inferior, even at high doses of synthetic
peptide (see Figs. 4(A) and 4(B)). It has been shown
that exogenously added peptides bind predomi-
nantly to preexisting MHC class II cell-surface mol-
ecules (Davidson et al., 1991). In mature B cells,
class II molecules are continuously endocytosed and
recycled to the cell surface (Harding et al., 1989;
Reid and Watts, 1990; Salamero et al., 1990). During
this recycling, MHC class II molecules may ex-
change peptides (Adorini et al., 1989). It may be
that in G12 pro-B cells, class II molecules do not
recycle properly, thereby rendering inefficient ex-
change of preexisting endogenous peptides for new
exogenous peptides in MHC binding sites. In con-
trast, endocytosed processed antigens bind to newly
synthesized MHC class II molecules in’acidic intra-
cellular compartments (Davidson et al., 1991). In
mature B cells, a class II-specific peptide loading
compartment has been described (Amigorena et al.,
1994; Tulp et al., 1994; West et al., 1994). It remains
to be seen if this specific compartment already exists
in pro-B/pre-B cells.
In conclusion, although evidence obtained with
class II-deficient mice suggests that MHC class II
expression per se does not seem to play an impor-
tant role in B-cell development (reviewed by Cardell
et al., 1994), our data indicate that initial expression
of the class II peptide-loading machinery may begin
at the pro-B-cell stage. The relative inefficiency of
exogenous Ag presentation by G12 pro-B cells sug-
gests that further maturation of their peptide-
loading compartment takes place during subsequent
stages of B-cell differentiation. It has been shown
that class II-restricted presentation of endogenously
synthesized antigens is much more efficient than
that of exogenously provided antigens (Calin-
Laurens et al., 1992). Hence, class II-restricted
presentation of exogenous and endogenous anti-
gens, by pro-B cells onwards to mature B cells, may
then occur in the bone marrow in vivo, where
thymus-dependent as well as thymus-independent
T cells have been found (Kubota et al., 1992;
Hozumi et al., 1993), in normal as well as in
pathological situations (Gravatt et al., 1993).
FIGURE 5. MHC class II-restricted presentation of the (A)
native HEL or (B) HEL(106-116) synthetic peptide by G12 cells to
the G28 T-cell hybridoma. M12.4.1 cells are represented by
triangles, G12 cells by empty squares, and IL-4-treated G12 cells
by filled squares. 3 x 10M12.4.1 cells or 105 G12 cells were
cocultured with 105 G28 T cells for 24 hr in the presence of
indicated concentrations of protein or 62.5 tg/ml of peptide.
Supematant was harvested and tested for the presence of IL-2
with CTLL.2 cells, as referred in Materials and Methods.
MATERIALS AND METHODS
Cell Lines
The 70Z/3 pre-B-cell line and the M12.4.1 mature
B-lymphoma-cell line were originally generated90 S. LOMBARD-PLATET et al.
from (C57BI/6 x DBA/2)F (BDF1) and Balb/c mice,
respectively, and have been described elsewhere
(Paige et al., 1978; Kim et al., 1979; Alt et al., 1984).
In our transgenic line, the mouse IL-7 cDNA is
under the control of the MHC class II Ea promoter
(Fisher et al., 1993). The BDF male founder mouse
no. 10 was crossed with a normal C57BI/6 female.
The transgenic progeny of this cross was again
backcrossed onto C57BI/6 and then crossed onto
DBA/2, giving rise to the 10-III-101 transgenic
mouse in which a tumor arose from which the G12
clone had been derived. G12 cells have been cloned
twice on IL-7-producing bone marrow stromal cells
B16.14. This latter cell line has been established
after immortalization of an adherent primary bone
marrow stromal-cell culture from transgenic mice
that had been infected with a recombinant retrovi-
rus encoding a thermosensitive form of the SV40 T
antigen (Fisher et al., 1993). The G28 HEL(106-
116)-specific I-Ed-restricted T-cell hybridoma has
been described (Lombard-Platet et al., 1993).
staining, incubations were made in the presence of
0.3% saponin, and washes with 0.1% saponin. The
rat In1.1 antibody was used to detect the presence
of the invariant chain (Koch and Hammerling,
1982).
PCR Assay
DNA was prepared as described (Haasner et al.,
1994). The PCR conditions and oligonucleotide
primers to amplify rearranged DH-JH fragments, or
germline fragments have been described (Gu et al.,
1991), with slight modifications reported by Fisher
et al. (1993). PCR samples were then separated on a
1% agarose gel and blotted onto a Hybond N
membrane (Amersham Corp., Arlington Heights,
IL). Filters were UV crosslinked, prehybridized, and
then hybridized with a radioactive JH4 oligonucle-
otide probe (5’-AGGAACCTCAGTCACCGGATC
CGT-3’) (Haasner et al., 1994).
Immunofluorescence Analysis
To analyze the cell-surface expression of B220,
Mac-l, and HSA, rat culture supernatants contain-
ing the monoclonal antibodies RA6B2, M1/70, and
J11d were used, respectively. The rat antibodies
were revealed with a 1:100 dilution of fluorescein
isothiocyanate-conjtgated goat anti-rat IgG
(CALTAG Laboratories, San Francisco). The rat
IgGab M5/114.15.2 (ATCC TIB120) (Bhattacharya
et al., 1981) monoclonal antibody was used for the
detection of MHC class II molecules. Negative con-
trol was made by incubation of rat IgG2b H35.17
CD8-specific antibody (Pierres et al., 1982). Expres-
sion of CD25 was analyzed with a phycoerythrin-
coupled mAb (Parmingen, San Diego). Negative
control was performed with a streptavidin-
phycoerythrin conjugate (Serotec, Oxford). The
binding of the following biotinylated antibodies:
AA4.1 (McKearn et al., 1985), BP-1 (Cooper et al.,
1986), Thy-1 (Becton Dickinson, San Jose, CA), B7.1
(Pharmingen, San Diego) and LM34 ()5-specific, a
kind gift of Dr. A. Rolink (Karasuyama et al., 1994)
were visualized with FITC-conjugated avidin (Bec-
ton Dickinson, San Jose). After staining, cells were
fixed in 1% paraformaldehyde. Flow cytometric
analyses were performed on a FACScan (Becton
Dickinson, Mountain View, CA). Ethidium bromide
(1 gg/ml) was added 2 min before analysis in order
to stain dead cells in the samples. For intracellular
Cell Culture and T-Cell Stimulation Assay
Cells were grown in DMEM (Gibco BRL, Grand
Island, NY) supplemented as previously described
(Lombard-Platet et al., 1993). B16.14 were main-
tained at 33C. Before using them as feeder layer
cells, they were treated for 45 min at 37C with 25
gg/ml mitomycin C (Sigma Chemicals, St. Louis),
and then extensively washed and seeded at 37C at
the ratio of approximately five B16.14 for one G12
cell. IL-4 containing supernatant was harvested
from X63 myeloma cells transfected with an expres-
sion vector encoding mouse IL-4 cDNA (Kara-
suyama and Melchers, 1988). Grade HEL was
purchased from Sigma Chemicals. HEL (106-116)
synthetic peptide was synthesized in this Institute.
T-cell stimulation assays were performed as previ-
ously described (Lombard-Platet et al., 1993). The
interleukin-2 content of culture supernatants was
measured using the CTLL-2 line. Proliferation of
CTLL-2 cells was evaluated by incorporation of
tritiated thymidine (DuPont NEN, Boston).
Detection of MHC Class II mRNA
RNA were prepared with the method of Chomczyn-
ski and Sacchi (1987). A 5’-end-labeled probe was
synthesized by primer extension. 10 pmoles of
primer-oligonucleotide (5’-GGAAGATGTTGTCCA
CAAAGcAGAT-3’) was labeled and annealed to a
single-stranded A template (a kind gift from Drs.MHC CLASS II IN PRO-B CELLS 91
D. Mathis and C. Benoist). The template/probe
hybrid was digested with 20 U Pstl. $1 mapping
was performed as described (Viville et al., 1991).
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